FYB202 is an interleukin inhibitor that can be used in dermatology to treat psoriasis and in gastroenterology to treat chronic inflammatory bowel disease. The biosimilar received marketing ...

Scientific publicationFormycon presents clinical data on ustekinumab biosimilar FYB202 at the ECCO Congress in Berlin 20.02.2025 / 06:30 CET/CESTThe issuer is solely responsible for the content of ...

How does PosterMyWall stack up? One of Canva's competitors now has AI-powered features, and we put them to the test.

Ruger’s debt-free balance sheet makes it a top choice over Smith & Wesson. Read why RGR and SWBI stocks may not be the best ...

Representative Jake Auchincloss discusses how the Democratic Party can offer meaningful alternatives to voters.

The Broad Institute and Illumina today announced their intent to collaborate on a groundbreaking Spatial Flagship Project, ...

The second day of the 9th "International Symposium on Current Trends in Drug Discovery Research” at CSIR-Central Drug Research Institute, Lucknow, observed important scientific deliberations by ...

Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...

All that money is doing more than just expanding Florida’s voucher program. The new rules are transforming it.

A 2023 reform has boosted voucher use by 67%, with one-quarter of state scholarships now going to families in the top income ...

When it comes to tau tangles, cortical deposits receive the lion’s share of scientists’ attention, but it is the tiny subcortical regions where tangles originate that might set the course for ...

Podcast: This episode explores whether children’s weaker selective attention is a hidden strength by addressing findings on attention, memory, and childhood learning.